Contrasting Avanos Medical (AVNS) and Its Competitors
Avanos Medical (NYSE: AVNS) is one of 28 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its peers? We will compare Avanos Medical to related businesses based on the strength of its valuation, profitability, dividends, institutional ownership, analyst recommendations, risk and earnings.
Earnings & Valuation
This table compares Avanos Medical and its peers gross revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Avanos Medical||$611.60 million||$79.30 million||30.76|
|Avanos Medical Competitors||$1.31 billion||$198.48 million||27.35|
This table compares Avanos Medical and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Avanos Medical Competitors||-166.86%||-201.11%||-22.18%|
Institutional and Insider Ownership
89.9% of Avanos Medical shares are owned by institutional investors. Comparatively, 58.8% of shares of all “Surgical appliances & supplies” companies are owned by institutional investors. 1.4% of Avanos Medical shares are owned by company insiders. Comparatively, 10.3% of shares of all “Surgical appliances & supplies” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Volatility and Risk
Avanos Medical has a beta of 1.6, meaning that its stock price is 60% more volatile than the S&P 500. Comparatively, Avanos Medical’s peers have a beta of 0.87, meaning that their average stock price is 13% less volatile than the S&P 500.
This is a summary of current ratings and target prices for Avanos Medical and its peers, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Avanos Medical Competitors||149||785||1393||71||2.58|
Avanos Medical currently has a consensus target price of $67.50, suggesting a potential downside of 6.63%. As a group, “Surgical appliances & supplies” companies have a potential downside of 1.22%. Given Avanos Medical’s peers stronger consensus rating and higher probable upside, analysts clearly believe Avanos Medical has less favorable growth aspects than its peers.
Avanos Medical beats its peers on 7 of the 13 factors compared.
About Avanos Medical
Avanos Medical, Inc. operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management. Its products include post-operative pain management solutions, minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. This segment sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and other brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.